![Hiro Nakauchi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hiro Nakauchi
Directeur/Membre du Conseil chez
University of Tokyo
Profil
Hiromitsu Nakauchi is the founder of ReproCELL, Inc. (founded in 2003), Century Therapeutics, Inc. (founded in 2018), and Celaid Therapeutics, Inc. (founded in 2020).
He is currently the Director & Professor at the University of Tokyo and a Professor at the University of Tsukuba.
Dr. Nakauchi obtained a doctorate degree from the University of Tokyo.
Postes actifs de Hiro Nakauchi
| Sociétés | Poste | Début |
|---|---|---|
University of Tokyo
 University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
University of Tsukuba
 University of Tsukuba Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Hiro Nakauchi
| Sociétés | Poste | Fin |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Fondateur | - |
Celaid Therapeutics, Inc.
 Celaid Therapeutics, Inc. BiotechnologyHealth Technology Develops cell therapies for treatment of cancer | Fondateur | - |
| REPROCELL INCORPORATED | Fondateur | - |
Formation de Hiro Nakauchi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
29
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Tokyo
University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Tsukuba
University of Tsukuba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ReproCELL, Inc.
 ReproCELL, Inc. Medical SpecialtiesHealth Technology Engages in the reagents for ES/iPS and stem cell-derived functional cells | Health Technology |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Celaid Therapeutics, Inc.
Celaid Therapeutics, Inc. BiotechnologyHealth Technology Develops cell therapies for treatment of cancer | Health Technology |
